Company news

Intervacc AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for Strangvac

July 30, 2026

Intervacc completes successful evaluation of US strain of strangles pathogen ahead of clinical trials

May 22, 2026

Emil Billbäck appointed new Chair of the Board of Intervacc

May 15, 2026

Intervacc strengthens management team for future growth

May 12, 2026

Intervacc publishes the 2025 Annual Report

April 14, 2026

Notice of Annual General Meeting in Intervacc AB (publ)

April 10, 2026

Intervacc announces breakthrough protection against Streptococcus suis infection in piglets

March 19, 2026

Intervacc: New CEO announced

February 6, 2026

Intervacc and Dechra extend distribution agreement for Intervacc’s equine strangles vaccine Strangvac by two years

October 13, 2025

Decks